Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC).
Standard
Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC). / Heider, Dirk; Bernert, Sebastian; König, Hans-Helmut; Matschinger, Herbert; Hogh, Theresa; Brugha, Traolach S; Bebbington, Paul E; Azorin, Michel; Angermeyer, Matthias C; Toumi, Mondher.
in: EUR PSYCHIAT, Jahrgang 24, Nr. 4, 4, 2009, S. 216-224.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC).
AU - Heider, Dirk
AU - Bernert, Sebastian
AU - König, Hans-Helmut
AU - Matschinger, Herbert
AU - Hogh, Theresa
AU - Brugha, Traolach S
AU - Bebbington, Paul E
AU - Azorin, Michel
AU - Angermeyer, Matthias C
AU - Toumi, Mondher
PY - 2009
Y1 - 2009
N2 - OBJECTIVES: To quantify and compare the resource consumption and direct costs of medical mental health care of patients suffering from schizophrenia in France, Germany and the United Kingdom. METHODS: In the European Cohort Study of Schizophrenia, a naturalistic two-year follow-up study, patients were recruited in France (N=288), Germany (N=618), and the United Kingdom (N=302). Data about the use of services and medication were collected. Unit cost data were obtained and transformed into United States Dollar Purchasing Power Parities (USD-PPP). Mean service use and costs were estimated using between-effects regression models. RESULTS: In the French/German/UK sample estimated means for a six-month period were respectively 5.7, 7.5 and 6.4 inpatient days, and 11.0, 1.3, and 0.7 day-clinic days. After controlling for age, sex, number of former hospitalizations and psychopathology (CGI score), mean costs were 3700/2815/3352 USD-PPP. CONCLUSIONS: Service use and estimated costs varied considerably between countries. The greatest differences were related to day-clinic use. The use of services was not consistently higher in one country than in the others. Estimated costs did not necessarily reflect the quantity of service use, since unit costs for individual types of service varied considerably between countries.
AB - OBJECTIVES: To quantify and compare the resource consumption and direct costs of medical mental health care of patients suffering from schizophrenia in France, Germany and the United Kingdom. METHODS: In the European Cohort Study of Schizophrenia, a naturalistic two-year follow-up study, patients were recruited in France (N=288), Germany (N=618), and the United Kingdom (N=302). Data about the use of services and medication were collected. Unit cost data were obtained and transformed into United States Dollar Purchasing Power Parities (USD-PPP). Mean service use and costs were estimated using between-effects regression models. RESULTS: In the French/German/UK sample estimated means for a six-month period were respectively 5.7, 7.5 and 6.4 inpatient days, and 11.0, 1.3, and 0.7 day-clinic days. After controlling for age, sex, number of former hospitalizations and psychopathology (CGI score), mean costs were 3700/2815/3352 USD-PPP. CONCLUSIONS: Service use and estimated costs varied considerably between countries. The greatest differences were related to day-clinic use. The use of services was not consistently higher in one country than in the others. Estimated costs did not necessarily reflect the quantity of service use, since unit costs for individual types of service varied considerably between countries.
KW - Adult
KW - Germany
KW - Humans
KW - Male
KW - Female
KW - National Health Programs economics
KW - numerical data
KW - Drug Costs statistics
KW - Health Care Costs statistics
KW - Schizophrenia economics
KW - Cohort Studies
KW - Cross-Cultural Comparison
KW - France
KW - Great Britain
KW - Health Services economics
KW - Health Services Accessibility statistics
KW - Health Surveys
KW - Insurance Claim Review statistics
KW - Mental Disorders economics
KW - Outcome Assessment (Health Care) statistics
KW - Adult
KW - Germany
KW - Humans
KW - Male
KW - Female
KW - National Health Programs economics
KW - numerical data
KW - Drug Costs statistics
KW - Health Care Costs statistics
KW - Schizophrenia economics
KW - Cohort Studies
KW - Cross-Cultural Comparison
KW - France
KW - Great Britain
KW - Health Services economics
KW - Health Services Accessibility statistics
KW - Health Surveys
KW - Insurance Claim Review statistics
KW - Mental Disorders economics
KW - Outcome Assessment (Health Care) statistics
M3 - SCORING: Zeitschriftenaufsatz
VL - 24
SP - 216
EP - 224
JO - EUR PSYCHIAT
JF - EUR PSYCHIAT
SN - 0924-9338
IS - 4
M1 - 4
ER -
